This Article Full Text (PDF) Other Versions of this Article: MCB.01282-06v1 27/1/283    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tong, X. Articles by Pelling, J. C. Search for Related Content PubMed PubMed Citation Articles by Tong, X. Articles by Pelling, J. C.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01282-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Apigenin Prevents UVB-induced Cyclooxygenase-2 Expression: Coupled mRNA Stabilization and Translational Inhibition

Department of Pathology, Feinberg School of Medicine, and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611; Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, and Department of Medicine, Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

^* To whom correspondence should be addressed. Email: j-pelling{at}northwestern.edu.

	Abstract

Cyclooxygenase-2 (COX-2) is a key enzyme in the conversion of arachidonic acid to prostaglandins and COX-2 overexpression plays an important role in carcinogenesis. Exposure to UVB strongly increased COX-2 protein expression in mouse 308 keratinocytes, and this induction was inhibited by apigenin, a nonmutagenic bioflavonoid that has been shown to prevent mouse skin carcinogenesis induced by both chemical carcinogens and UV exposure. Our previous study has suggested that one pathway by which apigenin inhibits UV-induced and basal COX-2 expression is through modulation of USF transcriptional activity in the 5' upstream region of the COX-2 gene. Here, we found that apigenin treatment also increased COX-2 mRNA stability and the inhibitory effect of apigenin on UVB-induced luciferase reporter gene activity was dependant on the AU-rich element (ARE) of COX-2 3' untranslated region (UTR). Furthermore, we identified two RNA binding proteins HuR and TIAR which were associated with endogenous COX-2 mRNA in 308 keratinocytes, and apigenin treatment increased their localization to cell cytoplasm. More importantly, reduction of HuR levels by siRNA inhibited apigenin-mediated stabilization of COX-2 mRNA. Cells expressing reduced TIAR showed marked resistance to apigenin's ability to inhibit UVB-induced COX-2 expression. Taken together, these results indicate that in addition to transcriptional regulation, another mechanism by which apigenin prevents COX-2 expression is through mediating TIAR suppression of translation.

This article has been cited by other articles:

• Abu-Yousif, A. O., Smith, K. A., Getsios, S., Green, K. J., Van Dross, R. T., Pelling, J. C. (2008). Enhancement of UVB-Induced Apoptosis by Apigenin in Human Keratinocytes and Organotypic Keratinocyte Cultures. Cancer Res. 68: 3057-3065 [Abstract] [Full Text]  
• Johann, A. M., Weigert, A., Eberhardt, W., Kuhn, A.-M., Barra, V., von Knethen, A., Pfeilschifter, J. M., Brune, B. (2008). Apoptotic Cell-Derived Sphingosine-1-Phosphate Promotes HuR-Dependent Cyclooxygenase-2 mRNA Stabilization and Protein Expression. J. Immunol. 180: 1239-1248 [Abstract] [Full Text]  
• Yamasaki, S., Stoecklin, G., Kedersha, N., Simarro, M., Anderson, P. (2007). T-cell Intracellular Antigen-1 (TIA-1)-induced Translational Silencing Promotes the Decay of Selected mRNAs. J. Biol. Chem. 282: 30070-30077 [Abstract] [Full Text]  
• Heier, C. R., Gogliotti, R. G., DiDonato, C. J. (2007). SMN Transcript Stability: Could Modulation of Messenger RNA Degradation Provide a Novel Therapy for Spinal Muscular Atrophy?. J Child Neurol 22: 1013-1018 [Abstract]